NYSE:DOCS Doximity (DOCS) Stock Price, News & Analysis $20.00 +0.61 (+3.12%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$19.89 -0.10 (-0.51%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Doximity Stock (NYSE:DOCS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Doximity alerts:Sign Up Key Stats Today's Range$19.28▼$20.0050-Day Range$17.94▼$26.4752-Week Range$17.15▼$76.51Volume3.48 million shsAverage Volume5.51 million shsMarket Capitalization$3.69 billionP/E Ratio20.20Dividend YieldN/APrice Target$30.62Consensus RatingHold Company Overview Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers. The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information. Doximity also provides mobile calling and faxing tools that let clinicians place calls from their personal devices using a professional number, and a searchable physician directory used by members and institutions. In addition to clinical communications, the platform hosts medical news and educational content, tools for earning continuing medical education (CME) credits, and resources that support medical training and career development. Doximity supports recruitment and talent solutions for healthcare organizations through a marketplace that helps employers identify and engage clinical candidates. It also publishes research and insights drawn from its professional network to inform healthcare trends, residency selection and workforce planning. The company primarily serves the U.S. healthcare market, where its network of licensed clinicians is concentrated, and partners with hospitals, health systems and medical institutions to deploy its enterprise services. Since becoming a public company in 2021, Doximity has positioned itself at the intersection of clinical workflow, professional networking and digital health services. Its business emphasizes product expansion that addresses clinician communication needs and institutional recruiting and marketing requirements while maintaining a focus on privacy and professional standards for healthcare users. AI Generated. May Contain Errors. Read More Doximity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScoreDOCS MarketRank™: Doximity scored higher than 82% of companies evaluated by MarketBeat, and ranked 12th out of 55 stocks in the services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingHold Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 2 strong buy ratings, 7 buy ratings, 13 hold ratings, and 1 sell rating.Upside PotentialDoximity has a consensus price target of $30.62, representing about 53.1% upside from its current price of $20.00.Amount of Analyst CoverageDoximity has been the subject of 21 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth18.18% Earnings GrowthEarnings for Doximity are expected to grow by 18.18% in the coming year, from $1.10 to $1.30 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 20.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.77.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 20.20, which means that it is trading at a more expensive P/E ratio than the Services sector average P/E ratio of about 9.12.Price to Earnings Growth RatioDoximity has a PEG Ratio of 2.59. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 3.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.40% of the float of Doximity has been sold short.Short Interest Ratio / Days to CoverDoximity has a short interest ratio ("days to cover") of 5.43.Change versus previous monthShort interest in Doximity has recently increased by 12.87%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.20 News SentimentDoximity has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.33 average news sentiment score of Services companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Doximity this week, compared to 6 articles on an average week.Search InterestOnly 24 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -4% compared to the previous 30 days.MarketBeat Follows4 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $456,061.00 in company stock.Percentage Held by Insiders31.30% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOCS Stock News HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCSMay 21 at 6:40 PM | prnewswire.comAI Reliance Poses Growing Operational, Regulatory, and Reputational Risks for DoximityMay 21 at 2:11 AM | tipranks.comOne filing just changed the SpaceX IPO foreverSpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price. | Behind the Markets (Ad)Doximity (DOCS) Receives a Hold from Truist FinancialMay 20, 2026 | theglobeandmail.comDoximity Leadership Shift And AI Push Reframe Growth And Valuation OutlookMay 20, 2026 | finance.yahoo.com5 revealing analyst questions from Doximity’s Q1 earnings callMay 20, 2026 | msn.comDoximity (NYSE:DOCS) Insider Siddharth Sitaram Sells 2,309 SharesMay 14, 2026 | insidertrades.comKira Scherer Wampler Sells 9,000 Shares of Doximity (NYSE:DOCS) StockMay 9, 2026 | insidertrades.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Doximity's stock was trading at $44.26 on January 1st, 2026. Since then, DOCS shares have decreased by 54.8% and is now trading at $19.9950. How were Doximity's earnings last quarter? Doximity, Inc. (NYSE:DOCS) released its earnings results on Thursday, February, 5th. The company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.45 by $0.01. Doximity's revenue for the quarter was up 9.8% on a year-over-year basis. Read the conference call transcript. How will Doximity's stock buyback program work? Doximity's board approved a stock buyback program on Thursday, February 5th 2026, which authorizes the company to buy back $500,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 8% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued. When did Doximity IPO? Doximity (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities acted as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's top institutional investors include Renaissance Technologies LLC (1.66%), SG Americas Securities LLC (0.76%), Dimensional Fund Advisors LP (0.74%) and Bank of America Corp DE (0.62%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Siddharth Sitaram, Regina M Benjamin, Kira Scherer Wampler, Watkin Phoebe L Yang and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Doximity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ). Company Calendar Last Earnings2/05/2026Today5/24/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (6m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 DOCS's financial health is in the Red zone, according to TradeSmith. DOCS has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorServices Industry Services – Computer Programming And Data Processing Sub-IndustryComputer Software Current SymbolNYSE:DOCS Previous SymbolNASDAQ:DOCS CIK1516513 WebN/A Phone(650) 549-4330FaxN/AEmployees890Year Founded2010Price Target and Rating Average Price Target for Doximity$30.62 High Price Target$65.00 Low Price Target$18.00 Potential Upside/Downside+53.1%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage23 Analysts Profitability EPS (Trailing Twelve Months)$0.99 Trailing P/E Ratio20.20 Forward P/E Ratio18.18 P/E Growth2.59Net Income$196.05 million Net Margins30.40% Pretax Margin38.77% Return on Equity20.40% Return on Assets17.43% Debt Debt-to-Equity RatioN/A Current Ratio6.09 Quick Ratio6.63 Sales & Book Value Annual Sales$644.86 million Price / Sales5.73 Cash Flow$1.23 per share Price / Cash Flow16.23 Book Value$5.15 per share Price / Book3.88Miscellaneous Outstanding Shares184,710,000Free Float126,895,000Market Cap$3.69 billion OptionableN/A Beta1.36 Social Links 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:DOCS) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredYou have until June 1Macroeconomic strategist Dr. Mark Skousen believes June 1 marks a critical turning point for one of the most o...The Oxford Club | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.